Literature DB >> 16756858

[Intimate partner violence. A survey conducted in the primary care setting].

Isabel Ruiz-Pérez1, Juncal Plazaola-Castaño, Pilar Blanco-Prieto, Juana María González-Barranco, Pilar Ayuso-Martín, María Isabel Montero-Piñar.   

Abstract

OBJECTIVES: To determine the prevalence of intimate partner violence (IPV) in a sample of women attending primary care centers for any reason and to analyze the characteristics of this violence.
METHODS: A cross sectional study was performed in 23 primary care centers in three regions of Spain (Andalusia, Madrid and Valencia). The sample included 1,402 randomly selected adult women aged between 18 and 65 years attending these centers. Among the variables collected through a self-administered questionnaire were the existence of physical, emotional or sexual abuse, and its timing, duration, and frequency.
RESULTS: Overall, 32% had experienced some type of IPV. By type, 7% had experienced both physical and emotional IPV, 14% had experienced emotional IPV, 3% had experienced emotional and sexual IPV, and 6% had suffered all 3 types of IPV. Among the latter, 52% had experienced abuse for more than 5 years. Women who experienced abuse in a previous relationship had a greater probability of being abused by a new intimate partner (OR = 3.30; 95% CI, 2.10-5.18).
CONCLUSIONS: These results show the scale of IPV in Spain. Health professionals play an important role in IPV, as they are in a privileged position to tackle this serious public health problem.

Entities:  

Mesh:

Year:  2006        PMID: 16756858     DOI: 10.1157/13088851

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  8 in total

Review 1.  Health-sector responses to intimate partner violence in low- and middle-income settings: a review of current models, challenges and opportunities.

Authors:  Manuela Colombini; Susannah Mayhew; Charlotte Watts
Journal:  Bull World Health Organ       Date:  2008-08       Impact factor: 9.408

2.  [Intimate partner violence: study with female nurses].

Authors:  María Aurora Rodríguez-Borrego; Manuel Vaquero Abellán; Liana Bertagnolli; Elisa Muñoz-Gomariz; Rosa Redondo-Pedraza; Adoración Muñoz-Alonso
Journal:  Aten Primaria       Date:  2011-03-15       Impact factor: 1.137

3.  A framework to analyse gender bias in epidemiological research.

Authors:  María Teresa Ruiz-Cantero; Carmen Vives-Cases; Lucía Artazcoz; Ana Delgado; Maria Mar García Calvente; Consuelo Miqueo; Isabel Montero; Rocío Ortiz; Elena Ronda; Isabel Ruiz; Carme Valls
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

4.  Prevalence and characteristics of intimate partner violence against women with severe mental illness: a prevalence study in Spain.

Authors:  Juan González Cases; Cristina Polo Usaola; Francisco González Aguado; Marisa López Gironés; Margarita Rullas Trincado; Alberto Fernández Liria
Journal:  Community Ment Health J       Date:  2014-01-29

5.  [Domestic violence: a screening question].

Authors:  Inmaculada Sala Musach; Ana Rosa Hernandez Alonso; Roser Ros Guitart; Gemma Lorenz Castañe; Neus Parellada Esquius
Journal:  Aten Primaria       Date:  2009-06-24       Impact factor: 1.137

6.  [Intimate partner violence. Types and risk in primary care health users in Cancun, Quintana Roo, Mexico].

Authors:  Luis Sandoval-Jurado; María Valeria Jiménez-Báez; Gloria Rovira Alcocer; Omar Vital Hernandez; Fany Guadalupe Pat Espadas
Journal:  Aten Primaria       Date:  2017-02-01       Impact factor: 1.137

Review 7.  Mapping and exploring health systems' response to intimate partner violence in Spain.

Authors:  Isabel Goicolea; Erica Briones-Vozmediano; Ann Ohman; Kerstin Edin; Fauhn Minvielle; Carmen Vives-Cases
Journal:  BMC Public Health       Date:  2013-12-10       Impact factor: 3.295

8.  [Gender violence: Knowledge and attitudes of nurses in Primary Care].

Authors:  Carmen Ana Valdés Sánchez; Carla García Fernández; Ángela Sierra Díaz
Journal:  Aten Primaria       Date:  2016-03-16       Impact factor: 1.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.